Stock data

軒郁 (6703)

軒郁 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$280.86M, up 35.9% from a year earlier. EPS over the last four quarters totals NT$9.53.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 軒郁 in Insightr